tallózása szerző szerint "Rubben H"

1-7 / 7

Circulating and tissue expression levels of YKL-40 in renal cell cancer

Vom Dorp F; Tschirdewahn S; Niedworok C; Reis H; Krause H; Kempkensteffen C; Busch J; Kramer G; Shariat SF; Nyirády, Péter; Rubben H; Szarvas, Tibor (2016)

PURPOSE: Blood levels of YKL-40 are elevated in various malignancies and other inflammatory diseases. Moreover, higher YKL-40 levels, have consequently been shown to correlate with poor prognosis in several cancers. The ...
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.

Szarvas, Tibor; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky, Ilona; Rubben H (2014)

In this study, we assessed the changes and prognostic relevance of syndecan-1 (SDC1) tissue and serum levels in bladder cancer (BC). SDC1 levels were analyzed in 213 samples (119 paraffin-embedded and 79 serum samples of ...
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma - occurence and prognostic significance

Módos, Orsolya; Reis H; Niedworok C; Rubben H; Szendrői, Attila; Szász, Attila; Tímár, József; Baghy K; Kovalszky I; Golabek T; Chlosta P; Okon K; Peyronnet B; Mathieu R; Shariat SF; Hollosi P; Nyirády, Péter; Szarvas, Tibor (2016)

PURPOSE: Targeted therapy represents an attractive alternative for rare tumors such as urachal carcinoma (UrC). The aim of this study was to assess the mutations of the most commonly affected 5 genes in the targetable ...
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.

Tschirdewahn S; Reis H; Niedworok C; Nyirády Péter; Szendrői Attila; Schmid KW; Shariat SF; Kramer G; Vom Dorp F; Rubben H; Szarvas T (2014)

OBJECTIVES: YKL-40 is a novel inflammatory serum protein shown to be associated with the presence and prognosis of several malignancies. However, its prognostic relevance has not yet been analyzed in bladder cancer (BC). ...
Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival

Niedworok C; Tschirdewahn S; Reis H; Lehmann N; Szűcs, Miklós; Nyirády, Péter; Romics, Imre; Rubben H; Szarvas, Tibor (2017)

Better prognostication of clinically localized prostate cancer (PCA) is urgently needed. Former studies using different study end-points provided controversial results regarding the prognostic value of serum chromogranin ...
Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer.

Szarvas, Tibor; Reis H; Vom Dorp F; Tschirdewahn S; Niedworok C; Nyirády, Péter; Schmid KW; Rubben H; Kovalszky, Ilona (2016)

BACKGROUND: PSA-screening detects many cases of clinically non-aggressive prostate cancer (PC) leading to significant overtreatment. Therefore, pre-operatively available prognostic biomarkers are needed to help therapy ...
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.

Niedworok C; Vom Dorp F; Tschirdewahn S; Rubben H; Reis H; Szűcs, Miklós; Szarvas, Tibor (2016)

PURPOSE: Despite encouraging results in other cancers, in renal cell cancer, no consensus exists regarding the diagnostic and prognostic relevance of MMP-7. The aim of this study was to assess the diagnostic and prognostic ...

1-7 / 7

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Rubben H"

DSpace/Manakin Repository

tallózása szerző szerint "Rubben H"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem